Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant

NCT03458897 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT03458897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03458897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Completed
Start date
May 3, 2018
Completion date
September 1, 2020
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease